Searched for
KOTAK ALTS
Kotak Alternate Asset Managers closes yield & growth fund at Rs 5,000 crore, raises entire corpus from domestic investorsKotak Alternate Asset Managers has closed its Kotak Yield & Growth Fund at Rs 5,000 crore, raised entirely from domestic investors. The Cat...- Private credit deals drop 61 pc to USD 3.5 bn in H1 2026: ReportPrivate credit deployments saw a sharp 61 percent drop in early 2026. This decline occurred amid a volatile macro economic environment and ...
- Kotak Alts raises $1 billion through 14th real estate fundKotak Alts has successfully raised one billion dollars for its fourteenth real estate fund. The Abu Dhabi Investment Authority anchored the...
- The New Age of Financial Accountability: Why Young India Is Demanding a Transparent Investing EcosystemYoung Indian investors are reshaping the country’s financial ecosystem by demanding greater transparency, credible research, and accountabl...
- Kotak Alternate Asset Managers launches Kotak Yield & Growth FundKotak Alternate Asset Managers launched the Kotak Yield & Growth Fund, aiming to deliver secure, credit-led yields with selective growth up...
- Kotak Alternate Assets bids Rs 7,400 crore for Jaiprakash Power Ventures, complicating Vedanta's plansKotak Alternate Assets has emerged as the highest bidder for Jaiprakash Power Ventures' preference shares and debt with a Rs 7,400 crore of...
- Prime Offices Fund acquires 3,00,000 sq ft commercial property in Delhi for Rs 760 CroreNuvama and Cushman & Wakefield's Prime Offices Fund bought a building in Delhi. The fund acquired 300,000 sq ft of space in Saket for Rs 76...
- Kotak arm invests Rs 1,050 cr in Tirupati MedicareKotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare to support its expansion and provide a complete exit for Af...
- Kotak arm invests Rs 1,050 cr in Tirupati MedicareKotak Alternate Asset Managers announced a Rs 1,050-crore investment in Tirupati Medicare to aid its expansion, enabling a full exit for Af...
- Kotak Strategic Situations Fund buys into Neuberg DiagnosticsKotak Strategic Situations India Fund II has invested Rs 940 Crore in Neuberg Diagnostics to support its inorganic expansion and prepare fo...
- PE Fund Multiples looks to sell HR Co PeopleStrong at Rs 1,500 crore valuationRenuka Ramnath-led Multiples Alternate Asset Management plans to sell its majority stake in HR platform PeopleStrong, valued at ₹1,300-₹1,5...
- Sify data centres ready to support AI servers with liquid cooling: CEOSify is one among the leading data centre operators with existing installed capacity of 190 MW in 12 centres across 6 cities Mumbai, Noida,...
- Dealmaker DAM Capital Advisors plans public issueDAM Capital, led by Dharmesh Mehta, targets an IPO within six months, highlighting Mumbai's investment-banking growth. Managed by Nuvama In...
- Kotak Alt invests Rs 1445 crore for the acquisition of Viatris' API business by Matrix PharmaKotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient (A...
- Kotak Alternate Asset Managers invests Rs 1,445 cr to help Matrix Pharma execute acquisitionKotak Alternate Asset Managers Ltd invested Rs 1,445 crore in Matrix Pharma for acquiring Vaitris' API business, making Matrix the 2nd larg...
- Kotak Alt to invest Rs 400 crore in medical device maker Biorad MedisysKotak Strategic Situations India Fund II (KSSF II) managed by Kotak Alternate Asset Managers Limited (Kotak Alt) announced investing up to ...
- Dons of Dalal Street: How a 3 Idiots dialogue led this fund manager to Asia’s top 25 influential women in AMC industryHaving started her journey researching on bond markets over 2 decades ago, Iyer went on to head the fixed income segment of India’s 5th lar...
- Stocks in the news: Jet Airways, Tata Motors, JB Chemicals, Sundaram Finance and Maruti SuzukiNomura has maintained 'buy' rating on Fortis Healthcare and cut target price to Rs 159.
- Buy Indo Count Industries, target Rs 215: Shrikant ChouhanBuy Indo Count Industries Ltd. at a price target of Rs 215.0 and a stop loss at Rs 199.0 from entry point
- HCL Tech is IT's stock market star with a growth rate of 64%Its revenue growth has been consistently high, and above the industry average growth. But what's been remarkable has been net profit growth.
Load More
